{"filing":{"accession_number":"0001493152-26-027045","cik":"0001433607","ticker":"NSPR","company_name":"InspireMD, Inc.","form":"8-K","filing_date":"2026-06-03","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1433607/000149315226027045/form8-k.htm"},"events":[{"id":7246,"run_id":6360,"accession_number":"0001493152-26-027045","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses results of InspireMD's 2026 annual meeting of stockholders held on June 3, 2026, with detailed voting tallies for three proposals: election of three directors (Marvin Slosman, Raymond Cohen, Dan Dearen), approval of an amendment to increase authorized common shares from 150M to 250M, and ratification of Kesselman \u0026 Kesselman as independent auditors. Item 5.07 explicitly presents the voting results with vote counts and percentages, which is the defining characteristic of shareholder_vote_results. The increase in authorized shares is material as it affects potential dilution and capital structure.","company_name":"InspireMD, Inc.","ticker":"NSPR","filing_date":"2026-06-03","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":4075,"accession_number":"0001493152-26-027045","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses results of InspireMD's 2026 annual meeting of stockholders held on June 3, 2026, with detailed voting tallies for three proposals: election of three directors (Marvin Slosman, Raymond Cohen, Dan Dearen), approval of an amendment to increase authorized common shares from 150M to 250M, and ratification of Kesselman \u0026 Kesselman as independent auditors. Item 5.07 explicitly presents the voting results with vote counts and percentages, which is the defining characteristic of shareholder_vote_results. The increase in authorized shares is material as it affects potential dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:45:57.083774+00:00","company_name":"InspireMD, Inc.","ticker":"NSPR","filing_date":"2026-06-03"}]}